Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia
Anodal & Cathodal tDCS for Treatment of Resistant Auditory Hallucinations in Schizophrenia
1 other identifier
interventional
46
2 countries
2
Brief Summary
The purpose of this study is to determine whether trans Direct Current Stimulation (tDCS) is effective in the treatment of auditory hallucinations in schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable schizophrenia
Started Feb 2009
Longer than P75 for not_applicable schizophrenia
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2009
CompletedFirst Submitted
Initial submission to the registry
March 26, 2009
CompletedFirst Posted
Study publicly available on registry
March 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 20, 2016
CompletedMarch 1, 2017
February 1, 2017
7.2 years
March 26, 2009
February 28, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Auditory hallucinations measured by Auditory Hallucination Rating Scale (Hoffman et al., 2003)
before, after 1 week of treatment and 2 times follow up (1 & 3 months)
Secondary Outcomes (1)
Neurochemical impact of treatment measured by 1H-MRS (proton Magnetic Resonance Spectroscopy), DTI (Diffusion Tensor Imaging) and resting MRI
3 times: before treatment, immediately after treatment and a last evaluation 1 month after
Study Arms (2)
active tDCS
ACTIVE COMPARATORtDCS active; - Intensity = 2 milliamps (mA) during 20 minutes. ramp up/ramp down 30sec anodal tDCS applied over the left DLPFC combined with cathodal tDCS applied over the left temporoparietal junction (TPJ). 10 sessions, 2 per day
sham tDCS
PLACEBO COMPARATORtDCS placebo same electrode montage than in the active group. 30 sec of active tDCS in the beginning of the stimulation sessions; ramp up/ramp down 30 sec
Interventions
Intensity 2 mA during 20 minutes, 2 times per day
Eligibility Criteria
You may qualify if:
- Schizophrenia according to Diagnostic and Statistical Manual - DSM-IV
- Auditory verbal hallucinations for at least 6 weeks (despite antipsychotic drugs)
- Medication Resistance according to Kane et al., 1988
- Age between 18 and 50 years old
- Informed consent
You may not qualify if:
- Concomitant major and unstable medical or neurologic illness
- Pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Hopital Le vinatier
Bron, 69677, France
Laboratoire de Recherche " Vulnérabilité Aux Psychoses "
Monastir, Tunisia
Related Publications (1)
Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012 Jul;169(7):719-24. doi: 10.1176/appi.ajp.2012.11071091.
PMID: 22581236DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
emmanuel poulet, MD, PhD
Hopital Le Vinatier
- STUDY DIRECTOR
JEROME BRUNELIN, PhD
Hopital le Vinatier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 26, 2009
First Posted
March 27, 2009
Study Start
February 2, 2009
Primary Completion
April 21, 2016
Study Completion
July 20, 2016
Last Updated
March 1, 2017
Record last verified: 2017-02